LATESTS NEWS FROM ACTALAB

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents

4 settimane ago

Besponsa: descrizione e gestione di specifiche reazioni avverse

Inotuzumab Ozogamicin verso Terapia Standard per la Leucemia Linfoblastica Acuta

Obinotuzumab in the treatment of Chronic Lymphocytic Leukemia

E’ oggi possibile prevedere nei soggetti anziani l’insorgenza di leucemia mieloide acuta?

Varianti germinali dc IKZF1 predispongono allo sviluppo della LAL nei bambini

The effects of catechins on related risk factors with Type 2 diabetes: a review

Influences of Physalis peruviana L. and Lupinus albus L. fruits extracts on the levels of some biochemical parameters in brain and muscle tissues of type II diabetic rats

Malnutrition rate among hospitalized patients with type 2 diabetes mellitus

Malnutrition rate among hospitalized patients with type 2 diabetes mellitus

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents

Read More

Recurrence of prostate cancer after HIFU. Proposal of a novel predictive index

Surgical therapy of cutaneous squamous cell carcinoma: our experience

FNA Cytology in pediatric small cell glioblastoma

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents

Dicembre 20, 2018

Besponsa: descrizione e gestione di specifiche reazioni avverse

Novembre 29, 2018

Inotuzumab Ozogamicin verso Terapia Standard per la Leucemia Linfoblastica Acuta

Novembre 7, 2018

#Follow us on Facebook